| Pharmaceutical active ingredients: |
| SulfadiazineSulfamerazineSulfamethazine |
| Available forms, composition and doses of Sulfa-Triple N2: |
| Tablets; Oral; Sulfadiazine 167 mg; Sulfamerazine 167 mg; Sulfamethazine 167 mg |
| Sulfa-Triple N2 medical category: |
| Human:Antibacterial combinations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Impax Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sulfonamides Duplex | Sulfadiazine; Sulfamerazine | Eli Lilly |
| Lantrisul | Sulfadiazine; Sulfamerazine; Sulfamethazine | Lannett |
| Neotrizine | Sulfadiazine; Sulfamerazine; Sulfamethazine | B. Braun; Eli Lilly |
| Sulfaloid | Sulfadiazine; Sulfamerazine; Sulfamethazine | Forest Laboratories |
| Sulfatril | Sulfadiazine; Sulfamerazine; Sulfamethazine | B L Hua |
| Sulfose | Sulfadiazine; Sulfamerazine; Sulfamethazine | Wyeth |
| Terfonyl | Sulfadiazine; Sulfamerazine; Sulfamethazine | Bristol-Myers Squibb |
| Tersulpha | Sulfadiazine; Sulfamerazine; Sulfamethazine | Lennon, South Africa; Aspen Pharmacare |
| Triple Sulfa | Sulfadiazine; Sulfamerazine; Sulfamethazine | Alpharma |
| Triple Sulfa | Sulfadiazine; Sulfamerazine; Sulfamethazine | Purepac Pharmaceuticals |